Oxaliplatin Injection, Solution
Product Images NDC 71288-149

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Oxaliplatin (NDC 71288-149). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Oxa0u 0000 01)

FDA Label Image

Figure 1 (Oxa0u 0000 02)

FDA Label Image

Figure 2 (Oxa0u 0000 03)

FDA Label Image

Figure 3 (Oxa0u 0000 04)

This is a clinical study comparing the median survival of patients receiving Oxaliplatin Injection plus 5-FU/LY with those receiving Irinotecan plus 5-FL. The median survival rate is presented graphically in terms of months of survival time. The statistical analysis shows a significant difference between the two groups (p<0.0001) using the log rank test.*

FDA Label Image

Premierprorx Logo (Oxa0u 0000 05)

FDA Label Image

Premierprorx Logo (Oxa0u 0000 06)

FDA Label Image

Principal Display Panel (Oxaliplatin Injection, USP 50 mg Vial Label)

This is a description of a medication with the NDC code 71288-149-95 called Beonty 3. It is an injection containing oxaliplatin (a cytotoxic agent) that is meant for intravenous use only. Each 10ml of the injection contains 50mg of oxaliplatin, with a concentration of 5mg per milliliter. The medication is made in India by Meitheal Pharmaceuticals Inc. and the label includes the code number AP/DRUGS/03/2011.*

FDA Label Image

Principal Display Panel (Oxaliplatin Injection, USP 50 mg Carton)

This is a product description for a solution called Oxaliplatin used as a cytotoxic agent for Intravenous use only, available in a single-dose vial. It includes information such as dosage and administration, storage requirements, and precautions. The solution is non-pyrogenic, and the container closure does not contain natural rubber latex. The package insert should be consulted for further information.*

FDA Label Image

Principal Display Panel (Oxaliplatin Injection, USP 100 mg Vial Label)

FDA Label Image

Principal Display Panel (Oxaliplatin Injection, USP 100 mg Carton)

This is a product description of Oxaliplatin Injection in a Single-Dose Vial for intravenous use only. The package insert includes dosage and administration instructions, as well as storage guidelines. The vial contains 100 mg Oxaliplatin USP and sterilized water for injection. It is important not to mix or add the solution to chloride/chloride-containing solutions. The NDC numbers and manufacturer are also listed.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.